JCVI: A New Selectable Marker for Manipulating the Simple Genomes of Mycoplasma
 
 
Section Banner

Publications

Citation

Algire, M. A., Lartigue, C., Thomas, D. W., Assad-Garcia, N., Glass, J. I., Merryman, C.

A New Selectable Marker for Manipulating the Simple Genomes of Mycoplasma

Antimicrob Agents Chemother. 2009 Aug 17;

PubMed Citation

Abstract

Over the past several years significant advancements have been made on the molecular genetics of the Mollicutes (the simplest cells that can be grown in axenic culture). Nevertheless, a number of basic molecular tools are still required before genetic manipulations become routine. Here we describe the development of a new dominant selectable marker based on the enzyme puromycin-N-acetyltransferase from Streptomyces alboniger. Puromycin is an antibiotic that mimics the 3'-terminal end of aminoacylated tRNAs and attaches to the carboxyl-terminus of growing protein chains. This stops protein synthesis. Because puromycin conscripts rRNA-recognition elements that are used by all of the various tRNAs in a cell, it is unlikely that spontaneous antibiotic resistance can be acquired via a simple point mutation-an annoying issue with existing mycoplasma markers. Our codon-optimized cassette confers pronounced puromycin resistance in all five of the mycoplasma species we have tested so far. The resistance cassette was also designed to function in Escherichia coli which simplifies the construction of shuttle vectors and makes it trivial to produce the large quantities of DNA generally necessary for mycoplasma transformation. Due to these and other features, we expect the puromycin marker to be a widely applicable tool for studying these simple cells and pathogens.